 | Up a level |
2020
Al-Sawaf, O., Robrecht, S., Fink, A., Ritgen, M., Johansson, P., Staber, P., Jaeger, U., Niemann, C., Pallasch, C., Kreuzer, K., Stilgenbauer, S., Fischer, K., Wendtner, C., Hallek, M. and Eichhorst, B. (2020). The CLL-RT1 trial: A multi-center phase-2 trial to evaluate the efficacy and safety of zanubrutinib, a BTK inhibitor, plus tislelizumab, a PD-1 inhibitor, for treatment of patients with Richter Transformation. Oncol. Res. Treat., 43 (SUPPL 4). S. 73 - 74. BASEL: KARGER. ISSN 2296-5262
Ladwig, A., Suh, J., Schweitzer, F., Roeth, P., Remke, G., Warnke, C., Schroeter, M., Izquierdo-Alvarez, E., Bonmann, E., Fink, G. R., Pallasch, C. and Lehmann, H. (2020). Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis. Mult. Scler. J., 26 (3_SUPPL). S. 259 - 260. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
2018
Busch, L., Mougiakakos, D., Bach, C., Buettner-Herold, M., Bittenbring, J. T., Neumann, F., Beier, F., Bisht, S., Nolting, J., Boettcher, M., Pallasch, C., Boxhammer, R., Spriewald, B. M., Mackensen, A. and Bruns, H. (2018). Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway. Oncol. Res. Treat., 41. S. 187 - 189. BASEL: KARGER. ISSN 2296-5262
2017
Vorholt, D., Erlikh, T., Feldkoetter, H., Nickel, N., Hallek, M. and Pallasch, C. (2017). Functional Implications and Interaction of macrophages in the leukemic microenvironment of CLL upon genotoxic stress. Oncol. Res. Treat., 40. S. 141 - 142. BASEL: KARGER. ISSN 2296-5262
2016
Al-Maarri, M., Nickel, N., Roth, A., Hoevelmeyer, N., Hallek, M., Wunderlich, F. T. and Pallasch, C. (2016). AKT ACTIVATION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS PROMOTES TRANSFORMATION TOWARDS AGGRESSIVE RICHTER'S SYNDROME LYMPHOMA. Haematologica, 101. S. 10 - 11. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Vorholt, D., Erlikh, T., Nickel, N., Hallek, M. and Pallasch, C. (2016). DIRECT AND INDIRECT MODULATION OF MACROPHAGES IN THE TUMOR MICROENVIRONMENT UPON GENOTOXIC STRESS ALTERS PHAGOCYTIC FUNCTION. Haematologica, 101. S. 421 - 423. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
2014
Berg, V, Vartak, N., Claasen, J., Rusch, M., Waldmann, H., Bastiaens, P., Hedberg, C., Pallasch, C., Hallek, M., Wendtner, C. and Frenzel, L. (2014). CD95 sensitivity of CLL cells is dependent on palmitoylation and controlled by a complex molecular network including miRNAs. Oncol. Res. Treat., 37. S. 237 - 238. BASEL: KARGER. ISSN 2296-5262
Huelsemann, M. F., Theurich, S., Becker, H. J., Pallasch, C., von Bergwelt-Baildon, M., Hallek, M., Wendtner, C. -M and Frenzel, L. P. (2014). p38 controls sensitivity to BH3 mimetics in CLL via regulation of Mcl-1. Oncol. Res. Treat., 37. S. 222 - 223. BASEL: KARGER. ISSN 2296-5262